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Abstract
Background: The MEK-ERK signaling pathway and autophagy play an important role for enterovirus71(EV71)
replication. Inhibition of MEK-ERK signaling pathway and autophagy is shown to impair EV71 replication. Berberine
(BBR), an isoquinoline alkaloid isolated from Berberis vulgaris L., has been reported to have ability to regulate this
signaling pathway and autophagy. Herein, we want to determine whether berberine can inhibit EV71 infection by
downregulating the MEK/ERK signaling pathway and autophagy.
Methods: The antiviral effect of berberine was determined by cytopathic effect (CPE) assay, western blotting
assay and qRT-PCR assay. The mechanism of BBR anti-virus was determined by western blotting assay and
immunofluorescence assay.
Results: We showed that berberine does-dependently reduced EV71 RNA and protein synthesis, which was, at least
in part, the result of inhibition of activation of MEK/ERK signaling pathway. Furthermore, we found that berberine
suppressed the EV71-induced autophagy by activating AKT protein and inhibiting the phosphorylation of JNK and
PI3KIII.
Conclusions: BBR inhibited EV71 replication by downregulating autophagy and MEK/ERK signaling pathway.
These findings suggest that BBR may be a potential agent or supplement against EV71 infection.
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Background
Enterovirus, which belongs to the Picornaviridae
family, is often associated with a serious infectious
disease affecting millions of people worldwide. In
particular, Enterovirus 71 (EV71) is the most com-
mon cause for hand, foot and mouth disease
(HFMD) in children under the age of five [1]. EV71
was first isolated from patients in California in 1969.
Since then, its outbreaks have been periodically
reported worldwide, especially in the Asia-Pacific
region. EV71-caused HFMD is often associated with
severe neurological diseases and fatalities. Unfortu-
nately, currently there are no effective antiviral drugs
in the clinic to treat EV71-induced HFMD [2, 3].
It is known that viruses successfully infect host
cells, needing toutilizemany functional components of
different cellular signaling pathways in cells. Mitogen
activated protein kinases (MAPKs) are important mol-
ecules mediating innate immunity in viral infection
and activation of the MEK/ERK MAPK signaling
pathway has been shown to be essential for EV71
replication in embryonic rhabdomyosarcoma (RD)
cells [4, 5], human embryonic kidney (HEK) 293 cells
[4], SK-N-SH cells [6] and immature dendritic (iDCs)
cells [7]. Inhibition of MEK/ERK signaling pathway by
U0126 or specific siRNAs has been found to impair
EV71 replication [4–7]. These recent studies strongly
supports that MEK/ERK signaling pathway plays an
essential role in EV71 life cycle and pathogenesis.
Therefore, blockage of MEK/ERK signaling pathway
may be an excellent strategy in limiting EV71
infection.
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In addition, virus-associated autophagy is also known
to provide a support for viral replication. Much evidence
shows that viral infection induces autophagy in host cells
including human cytomegalovirus [8], hepatitis C virus
[9], herpes simplex virus type I [10], coxsackievirus B3
[11], influenza A virus [12], human immunodeficiency
virus type I [13], and EV71 [14–16]. Autophagy induced
by viruses infection may provide a support for viruses
replication. It has been reported that EV71 infection
could induce autophagic machinery to promote EV71
replication in vivo and in vitro [14]. Fu et al. demon-
strated that EV71 infection African green monkey kindy
cells (Vero) induced autophagy and they identified a
miRNA, miR-30a, that inhibited EV71 replication by
modulating EV71-induced autophagy [16]. Lee et al.
found that EV71-induced autophagy increases viral repli-
cation and pathogenesis in a suckling mouse model [17].
Therefore, therapeutic modulation of autophagy may be
a promising strategy for inhibiting EV71 replication.
Berberine (BBR, Fig. 1a), an isoquinoline alkaloid iso-
lated from Berberis vulgaris L., has been reported to
have multi pharmacological effects such as antidiarrheal
effect [18], antibacterial effect [19], hypotensive effect
[20], and antiviral activity [21, 22]. Most of these
pharmacological effects is known to be associated with
the mechanisms that BBR regulates signaling pathway in
vitro, such as, EGFR/MEK/ERK signaling pathway [23],
NF-κB pathway [22], AMPK/mTOR signaling pathway
[24]. In addition, Deng et al. demonstrated that BBR at-
tenuates autophagy in adipocytes by targeting BECN1
[25]. These findings suggest that BBR can regulate
MEK/ERK signaling pathway and autophagy, which im-
plies that BBR might be effective in limiting viral replica-
tion. In line with this notion, BBR is shown to inhibit
the replication of respiratory syncytial virus (RSV),
herpes simplex virus (HSV), human papilomavirus
(HPV), and human cytomegalovirus (HCMV) [21, 22,
26, 27]. However, it is unclear that BBR has an inhibitory
action against EV71. Herein, the aim of our research is
to determine whether BBR inhibits EV71 replication by
downregulating autophagy and MEK/ERK signaling
pathway.
Results
BBR inhibits EV71 replication
To determine the anti-EV71 activities of the tested com-
pounds, their abilities to inhibit EV71-induced CPE in
Vero cells. First, we first detected the toxicity of BBR
and pirodavir in Vero cells by Cell Counting Kit (CCK)
assay (Fig.1c, d). As shown in Table 1, the 50% toxicity
concentration (TC50) of BBR was 73.10 μmol/L in Vero
cells and the TC50 of pirodavir (Fig. 1b) was 27.49 μmol/L
in Vero cells.
Next,we performed CPE assays according to the above
results. We found that BBR significantly inhibited the
replication of all the tested strains, including H, JS-52,
Fig. 1 The chemical structure of compounds and CCK assay. a The chemical structure of BBR. b The chemical structure of pirodavir. c The CCK
assay of BBR. d The CCK assay of pirodavir
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SHZH98 and BrCr stains, with the 50% inhibitory con-
centration (IC50) values ranging from 7.43 to 10.25 μM
(Table 1).
Similarly, the activity of BBR anti-EV71 virus also visu-
ally demonstrated with electron microscope photograph
and crystal violet staining in Vero cells (Fig.2a and b).
To futher confirm the inhibitory action of BBR and piro-
davir against EV71, the expression of VP1 and EV71
capsid protein, was analyzed to examine its effect on
EV71 biological synthesis. As shown in Fig. 2d, BBR
decreased the expression of VP1 protein in a dose
dependent manner. In the same way, BBR treatment
dose-dependently decreased the level of VP1 RNA
measured by reverse transcription-quantitative poly-
merase chain reaction (RT-qPCR) assay (Fig. 2c). The
reference drug Pirodavir also significantly decreased
the RNA and protein synthesis of EV71. Collectively,
BBR demonstrated a potent inhibitory activity against
EV71 virus.
BBR inhibits the phosphorylation of MEK/ERK signaling
pathway
It was known that MEK/ERK were downstream compo-
nents of epidermal growth factor receptor (EGFR)
signaling pathways which can be activated by several
stimulus including EV71 infection in various cell types
[6, 28]. Inhibition of MEK/ERK signaling pathway by
U0126 or specific siRNAs has been found to impair
EV71 replication [4–7] and BBR was reported to regu-
late this signaling pathway in vitro. Thus, we assessed
whether BBR affected EV71 replication by regulating the
phosphorylation of MEK/ERK. As shown in Fig.3, both
BBR and poridavir inhibited EV71 replication. However,
the phosphorylation of MEK/ERK was significantly
attenuated by treatment with BBR but not pirodavir.
BBR inhibits EV71-induced autophagy
Autophagy induced by virus infection provides a support
for viral replication. It has been reported that EV71
Table 1 The efficiency of BBR and pirodavir against EV71 in vitro
Pirodavir BBR
TC50 (μM) IC50 (μM) SI TC50 (μM) IC50 (μM) SI
EV71(H) 27.49 ± 5.18 0.41 ± 0 67.05 73.10 ± 0.79 8.55 ± 0 8.55
EV71(SHZH98) 27.49 ± 5.18 0.26 ± 0.05 105.73 73.10 ± 0.79 10.25 ± 7.24 7.13
EV71(JS-52) 27.49 ± 5.18 0.47 ± 0.08 58.49 73.10 ± 0.79 7.43 ± 1.59 9.84
EV71(BrCr) 27.49 ± 5.18 0.22 ± 0.11 124.95 73.10 ± 0.79 7.43 ± 1.59 9.84
Values provided in this table represent the mean of three independent experiments
Fig. 2 The antiviral effect of BBR and pirodavir against EV71 in Vero. a BBR and pirodavir reduced the EV71-induced CPE in Vero cells. Cells were
examined using a microscopy (×40). b BBR and pirodavir reduced the EV71-induced CPE in Vero cells. Cells were examined using crystal violet
staining. c BBR and pirodavir reduced the expression of EV71 VP1 RNA by one-step qRT-PCR assay. **P < 0.001 *P < 0.05 d BBR and pirodavir
reduced the expression of EV71 VP1 protein in Vero cells by western blot assay
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infection could induce autophagic machinery to promote
EV71 replication in vivo and in vitro [14]. JNK signaling
pathway plays an important role in regulation of cell
growth, proliferation, differentiation, migration and
apoptosis. Studies have shown that JNK signaling path-
way is closely related to autophagy, and inhibition of
JNK signaling pathway could inhibit autophagy. PI3KIII,
as an upstream activator of autophagy, plays an import-
ant role in autophagy.
Otherwise, AKT, as an upstream regulator of autoph-
agy, is usually considered to be an autophagy inhibitor.
We speculated that BBR inhibited EV71-induced
autophagy by affecting JNK, PI3KIII and AKT signaling
pathway. As shown in Fig.4a, BBR increased AKT
Fig. 3 BBR but not pirodavir reduces the phosphorylation of MEK/ERK. Vero cells (9 × 105 cells/well) were plated into 6-well culture plates. Vero
cells were mock-infected or infected with EV71 (H, MOI = 0.1) for 1 h. The cells were then treated with BBR (40 μmol/L) and pirodavir (0.5 μmol/L),
respectively, for 24 h. The cells were harvested and proteins were examined by western blot
Fig. 4 BBR could inhibit EV71-induced autophagy. (a, b) BBR but not pirodavir can reduce EV71-induced autophagy. Vero cells were mock-infected or
infected with EV71 (H, MOI = 0.1) for 1 h. The cells were then treated with BBR (40 μmol/L) and pirodavir (0.5 μmol/L), respectively, for 24 h. The cells
were harvested and proteins were examined by western blot. (c) BBR and 3-MA could both reduce EV71 infection by inhibiting autophagy. Vero cells
were mock-infected or infected with EV71 (H, MOI = 0.1) for 1 h. The cells were then treated with BBR (40 μmol/L) and 3-MA (5 μmol/L), respectively,
for 24 h. The cells were harvested and proteins were examined by western blot
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phosphorylation and reduce JNK and PI3KIII phosphor-
ylation. Accordingly, we found that the lapidated
LC3BII, a marker for autophagy, decreased in the pres-
ence of BBR. Consistent with this, the amount of
SQSTM1/P62 increased in BBR-treated cells compared
to virus control, which suggested that BBR was effective
in inhibiting autophagy. However, BECN-1 expression
was not affected by BBR (Fig.4b). To further confirm the
result of BBR inhibition of autophagy, we next used
fluorescence microscopy to observe the effect of BBR on
EV71-induce autophagy. As shown in Fig.5, LC3B
expression was inhibited by BBR not pirodavir in EV71-
infected Vero cells. Similarly, 3-MA, an autophagy
suppressor, could also inhibit EV71 replication (Fig.4c).
Therefore, EV71-induced autophagy in Vero cells was
attenuated by BBR but not pirodavir although both two
compounds could inhibit EV71 replication.
Discussion
EV71, a member of the Picornaviridae family, causes
HFMD by spreading through contact with virus-
containing body fluids, respiratory droplets, and feces.
However, there are no effective antiviral drugs available
for the treatment of HFMD. Some natural medicinal
compounds have been demonstrated to be active against
the disease by ameliorating the symptoms and shorten-
ing the course [29, 30]. Three capsid-targeting molecules
known as “WIN” compounds are currently in clinical
development [31, 32]. According to our results (date not
shown), the antiviral activity of pirodavir against EV71 is
better than pleconaril. Thus, we used pirodavir as posi-
tive control for the evaluation of the antiviral activity of
BBR.
BBR has been reported to have multi pharmacological
effects such as antibacterial effect [19], hypotensive
effect [33], and antiviral activity [21, 22]. It has been
reported that BBR could regulate signaling pathway in
vitro, such as, EGFR/MEK/ERK signaling pathway [23],
AMPK/mTOR signaling pathway [24]. It is interesting
thing that BBR should promote EV71 replication since
BBR activated ERK, which is required for the viral repli-
cation. However, BBR exhibited inhibited activity against
EV71 in a dose-dependent manner. BBR inhibited the
activation MEK/ERK signaling pathway in Vero cells.
Fig. 5 BBR could inhibit EV71-induced autophagy. BBR but not pirodavir can reduce EV71-induced autophagy by immunofluorescence assay. Vero
cells were mock-infected or infected with EV71 (H, MOI = 0.1) for 1 h. The cells were then treated with BBR (40 μmol/L) and pirodavir (0.5 μmol/L),
respectively, for 24 h. Cells were examined using a fluorescence microscopy (×400)
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Also, Liu et al. found that BBR induced senescence of
human glioblastoma cells by downregulating the EGFR/
MEK/ERK signaling pathway [23]. We thus think that
BBR may have different effects on the same signaling
pathway in different cell lines.
Otherwise, the preliminary analysis indicated that BBR
inhibited EV71-induced autophagy. BBR suppressed
LC3BII in both normal Vero cells and EV71-infected
Vero cells. These findings suggest that BBR inhibits
EV71 replication,at least partly by inhibiting autophagy.
Of note, several studies showed that BBR also upregu-
lated autophagy in some cell lines such as J774A.1 cells
[24] and HepG2 cells [34]. Obviously, it is very possible
that BBR has different effect on autophagy in different
cell lines.
Overall, our research is the first time to report the
anti-EV71 mechanism of BBR and our findings provide
a new clue for developing the anti-EV71 drug by inhibit-
ing MEK/ERK signaling and EV71-induced autophagy.
However, many questions remain to be solved, e.g.,
whether berberine is effective in limiting EV71 infection
in vivo. In future, we would further explore these ques-
tions in mouse models prior to clinical trials in further
studies.
Conclusions
In this study, we found that BBR inhibited EV71-
induced autophagy and the activation of MEK/ERK
signaling pathway. These findings suggest that berberine
might be a potential lead or supplement for the develop-
ment of new anti-EV71 agent in the future.
Methods
Cells and viruses
African green monkey kidney (Vero) cells were pur-
chased from the American Type Culture Collection
(ATCC), and were cultured in Minimum Essential
Medium (MEM) supplemented with 10% fetal bovine
serum (FBS) (GIBCO) and antibiotics (100 U/ml penicil-
lin and 100 mg/ml streptomycin) at 37 °C in a 5% CO2
incubator.
EV71 strain SHZH98 isolated from the throat swab sam-
ple of an HFMD case occurring in 1998 in China was
kindly provided by Dr. Qi Jin, Institute of Pathogen Biology,
Chinese Academy of Medical Science and Peking Union
Medical School, Beijing, China. EV71 strain BrCr (VR-
1775) and H (VR-1432) were purchased from the ATCC.
EV71 strain JS-52 was a kind gift from Dr. Xiangzhong Ye,
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
EV71 were all passaged in Vero cells.
Compounds
BBR was purchased from the Sigma-Aldrich (St Louis,
MO, USA) and the purity is no less than 99%. Pirodavir
was purchased from Biochempartner (Shanghai, China).
Both BBR and piradavir were dissolved into DMSO.
Cytotoxicity assay
Cytotoxic effects of BBR on Vero cells were assayed
by CCK (TransGen Biotech, China) assay. Briefly,
cells (3 × 104 cells/well) were seeded into 96-well
culture plates and were incubated overnight. Then,
the medium was removed and different concentra-
tions of BBR were applied in triplicate. After 3 days’
incubation, the cytotoxicity of BBR was determined
by CCK assay. The signals were read at 450 nm on
Enspire (Perkin Elmer,Waltham, MA, USA). The TC50
was defined as the concentration that inhibits 50%
cellular growth in comparison with the controls.
CPE inhibition assay for anti-EV71
The anti-EV71 activity of BBR was assayed by CPE in-
hibition method. Briefly, cells (3 × 104 cells/well) were
plated into 96-well culture plates for incubation of 24 h.
The medium was then removed and cells were infected
with EV71 of 100TCID50 (50% tissue culture infective
doses) in serum-free medium for 1 h at 37 °C. Then, the
unbound viruses were removed and various concentra-
tions of BBR were supplemented for incubation of
another 48 h. The IC50 defined as the minimal concen-
tration of inhibitor required to inhibit 50% of CPE was
determined by Reed & Muench method. The selectivity
index (SI) was calculated as the ratio of TC50/IC50 . In
addition, the cells were stained with 0.5% crystal violet
in 20% ethanol for 15 min at room temperature and the
cells were imaged after rinsed with PBS.
Western blot analysis
The cells were lysed in the M-PER mammalian protein
extraction reagent (Thermo, Rockford, IL) containing
halt protease inhibitor single-use cocktail (Thermo). The
protein concentration was determined by the BCA re-
agents (Thermo). About 15 μg proteins were denatured
and applied to sodium dodecyl sulfate-polyacrylamide
gel electrophoresis (SDS-PAGE). The electrophoresis
products were transferred to a polyvinyl idenefluoride
(PVDF) film and PVDF membranes were then incubated
at room temperature with specific primary antibody.
After a standard washing, membranes were incubated
with horse radish peroxidase (HRP)-labeled secondary
antibody. The assay developed using a chemiluminescent
substrate. The primary antibodies used in this study in-
cluded antibodies against β-actin, p-p44/p42 MAPK,
p44/p42 MAPK, p-MEK, MEK, p-AKT, AKT, p-JNK,
JNK, PI3KIII, SQSTM1/P62, LC3B, Beclin-1 (Cell
Signaling Technology), and EV71-VP1 (Abnova). The
goat anti-rabbit and anti-mouse HRP-labeled antibodies
were obtained from Cell Signaling Technology.
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Immunofluorescence assay
Vero cells grown on glass coverslips (Thermo) were in-
fected with EV71 (H, MOI = 0.1) for 1 h. Then, BBR and
pirodavir were supplemented for incubation of another
24 h. After incubation, the culture medium was removed
and the cells were washed and fixed. The cells were
permeabilized in 0.5% Triton X-100 at room temperature
for 15 min and blocked in PBS containing 1% BSA for
60 min at room temperature. Cells were then incubated
with an anti-EV71 antibody (Millipore) and LC3B (Cell
Signaling Technology) antibody at a dilution of 1: 500 for
2 h at room temperature. After washing three times with
PBS, the samples were reacted with PE conjugate goat
anti-mouse secondary antibody (TransGen Biotech,
China) and FITC conjugate goat anti-rabbit secondary
antibody (TransGen Biotech, China) at a dilution of 1: 500
for 1 h at room temperature. After washing with PBS, add
Hoechst (Beyotime Institute of Biotechnology, China) for
10 min and images were taken using a fluorescence micro-
scope (Olympus, IX71).
Quantitative reverse-transcription polymerase chain
reaction (qRT-PCR) quantification
Vero cells (9 × 105cells/well) were plated into 6-well
culture plates for incubation of 16 h. The medium was
removed and cells were infected with EV71 (H, MOI =
0.1). After 1 h, various concentrations of BBR were
supplemented for incubation of another 24 h. The total
RNA of the infected cells was extracted using the
RNeasy Mini kit (QIAGEN) according to the manufac-
turer’s instructions. The one-step qRT-PCR was
performed with SuperScript III Platinum SYBR Green
One-step RT PCR Kit (Invitrogen) using the ABI 7500
Fast Real-Time PCR system (Applied Biosystems). The
mRNA expression of EV71 VP1 was detected with sense
primer 5′- GATATCCCACATTCGGTGA -3′ and anti-
sense primer 5′- TAGGACACGCTCCATACTCAAG
-3′ targeting a conserved region of the VP1 gene. The β-
actin mRNA was detected using sense primers 5′-TG
ACGGGGT CACCCACA CTGTGCCCATCTA-3′ and
antisense primer 5′-CTAGAAGCATTTG CGGTGGAC
G ATG-3′. PCR assay was carried out in a 25 μL volume
and the target fragment amplification was carried out as
follows: reverse transcription at 50 °C for 3 min; initial
activation of HotStar Taq DNA Polymerase at 95 °C for
10 min; 40 cycles in two steps: 95 °C for 15 s, 60 °C for
30s. The relative amounts of EV71 VP1 mRNA was
calculated by comparative Ct method after normalizing
the quantity of β-actin.
Statistical analysis
Data are expressed as the mean ± standard error of the
mean and analyzed using two-tailed Student’s t-tests
with P < 0.001 and P < 0.05 taken as significant.
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